U.S. market Closed. Opens in 11 hours 25 minutes

ABVC | ABVC BioPharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-12-312005-12-312004-12-312003-12-312002-12-31
Revenue152.43K969.78K355.80K483.05K701.72K6.96KN/AN/AN/A3.36KN/A7.79K5.71K3.19K14.86KN/A25.09K41.67KN/AN/A57.49K13.67K10.00K
Cost of Revenue330.57K286.42K5.09K18.72K20.14K185.28KN/AN/A32.00521.00N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A32.39K25.76K10.00K
Gross Profit-178.14K683.37K350.71K464.33K681.58K-178.32KN/AN/A-32.002.84KN/A7.79K5.71K3.19K14.86KN/A25.09K41.67KN/AN/A25.10K-12.09KN/A
Operating Expenses8.04M15.80M11.70M8.97M4.14M1.39M4.14M4.00M4.50M35.12K70.00185.05K1.15M1.89M1.70M4.91M5.38M4.46M26.82K17.57K23.10K11.72K20.00K
Selling, General & Admin6.98M13.10M11.05M8.42M3.09M723.95K967.09K1.55M8.99M35.12KN/AN/AN/A1.89M1.90M4.91M5.38M4.46M26.82K17.57K23.10K11.72K20.00K
Research & Development1.06M2.69M1.00M549.66K1.05M669.67K3.17M3.15MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating Expenses69.28K83.00K-360.90K199.64K116.85KN/A63.39K-707.14K-4.50MN/A70.00185.05K1.15MN/A-206.98KN/AN/AN/AN/AN/AN/AN/A0
Operating Income-8.22M-15.11M-11.35M-8.51M-3.46M-1.39M-4.14M-4.00M-4.50M-32.28K-70.00-177.26K-1.14M-1.89M-1.68M-4.91M-5.35M-4.42M-26.82K-17.57K2.01K-23.80K-20.00K
Other Expenses / Income-2.44M-400.18K134.24K-2.31M-551.50K-2.55M-4.82M-74.81K-9.67KN/AN/A-49.09K141.10K874.13KN/AN/AN/AN/A1.43K1.21K532.00-1.56KN/A
Before Tax Income-10.65M-15.51M-11.21M-10.81M-4.01M-4.10M-4.24M-4.07M-4.51M-32.28K-70.00-226.35K-1.00MN/AN/AN/AN/AN/A-25.40K-16.36K2.54K-25.36K-20.00K
Income Tax Expenses256.01K797.78K825.02K-220.35K-77.04K1.85K830.00830.00836.00N/AN/AN/A67.64KN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Income-10.52M-16.31M-12.04M-10.59M-3.93M-4.10M-4.24M-4.07M-4.51M-32.28K-70.00-226.35K-1.07M-1.22M-1.90M-5.18M-6.77M-4.65M-25.40K-26.67K2.54K-25.36K-20.00K
Interest Expenses2.49M293.97K227.21K405.03K482.01K155.93K103.46K74.96K10.17KN/AN/A49.09K87.70K204.92K218.57K271.86K1.42M256.51KN/AN/AN/A1.56KN/A
Basic Shares Outstanding4.34M3.17M2.51M1.97M1.75M1.16M1.71M11.81M10.78M872.67K1.91K1.91K1.01K494.00229.00229.002.23K3.67K3.67K224.00224.00224.00224.00
Diluted Shares Outstanding4.34M3.17M2.51M1.97M1.75M1.19M1.71M11.81M10.78M872.67K1.91K1.91K1.01K494.00229.00229.002.23K3.67K3.67K224.00224.00224.00224.00
EBITDA-8.19M-14.82M-11.13M-8.20M-3.26M-1.39M-4.09M-4.00M-4.50M-32.28K-70.00-153.40K-881.20K-979.55K-1.64M-4.87M-5.31M-4.38M-26.82K-17.57K2.54K-23.80K-20.00K
EBITDA Margin-5,371.63%-1,528.16%-3,127.65%-1,697.14%-465.07%-20,033.40%0.00%0.00%0.00%-960.74%0.00%-1,969.95%-15,421.68%-30,707.05%-11,017.78%0.00%-21,167.87%-10,515.51%0.00%0.00%4.42%-174.13%-200.00%
EBIT-7.77M-15.22M-10.98M-10.41M-3.53M-3.94M-4.14M-4.00M-4.50M-32.28K-70.00-177.26K-914.24K-1.01M-1.68M-4.91M-5.35M-4.39M-25.40K-26.67K2.54K-23.80K-20.00K
EBIT Margin-5,095.00%-1,569.49%-3,087.05%-2,154.85%-502.80%-56,692.40%0.00%0.00%0.00%-960.74%0.00%-2,276.35%-16,000.07%-31,778.50%-11,322.27%0.00%-21,317.26%-10,546.12%0.00%0.00%4.42%-174.13%-200.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-12-312005-12-312004-12-312003-12-312002-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙